Replies to post #58949 on NorthWest Biotherapeutics Inc (NWBO)

[TheFollower]

Woodford has positioned himself to take advantage of a short squeeze, strategically selling a portion of his shares in the event that it should happen, I believe.

From the SEC filing
https://www.sec.gov/Archives/edgar/data/1072379/000114420416075320/0001144204-16-075320-index.htm

Northwest Biotherapeutics, Inc. (the “Company”) is filing this prospectus supplement and accompanying prospectus to register for potential resale 15,177,739 previously-issued shares (the “Shares”) of our common stock, par value $0.001 per share (the “Common Stock”) sold to Woodford Investment Management LLP (“Woodford”, or the “Selling Shareholder”) in three separate transactions. On November 17, 2014, we entered into a Stock Purchase Agreement with Woodford to sell 4,317,789 shares of Common Stock at the price of $5.79 per share. On April 2, 2015, we entered into a Stock Purchase Agreement with Woodford to sell 5,405,405 shares of Common Stock in two, separate installments, each at the price of $7.40 per share. On October 21, 2015, we entered into a Stock Purchase Agreement with Woodford to sell 5,454,545 shares of Common Stock at the price of $5.50 per share. Pursuant to each of the Stock Purchase Agreements, we agreed to register the Shares on behalf of Woodford.